tranexamic acid has been researched along with hydroquinone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aljuffali, IA; Chen, CC; Chen, WY; Fang, JY; Hsieh, PW | 1 |
| Banihashemi, M; Jaafari, MR; Jabari, A; Salehi, M; Zabolinejad, N | 1 |
| Choi, SC; Jung, JY; Kwon, HH; Kwon, IH; Ohn, J; Park, GH; Park, HY; Suh, DH | 1 |
| Abedini, R; Akbari, Z; Ghayoumi, A; Goodarzi, A; Hedayat, K; Hosseini, H; Lajevardi, V | 1 |
| Darayesh, M; Heiran, A; Saki, N | 1 |
| Feng, C; Yan, M | 1 |
| Hamzavi, I; Lyons, AB; Peacock, A; Vellaichamy, G; Zubair, R | 1 |
| Spierings, NMK | 1 |
| Anwar, AI; Budhiani, S; Nurdin, AR; Seweng, A; Wahab, S; Widita, W | 1 |
| Agustin, T; Legiawati, L; Pandya, AG; Prihartono, J; Shihab, N; Tovar-Garza, A | 1 |
| Arreola Jauregui, IE; Baeza Echeverría, AE; Huerta Rivera, G; López Zaldo, JB; Madrid Carrillo, C; Meyer-Nava, I; Meyer-Nava, S; Paniagua Santos, JE; Soria Orozco, M; Vázquez Huerta, M; Zaldo Rolón, IE | 1 |
| Jawade, S; Kulkarni, S; Madke, B; Sahu, PJ; Saoji, V; Singh, AL | 1 |
| Aljabban, A; Bain, PA; Bay, CP; Chang, YF; Chung, HJ; Desai, SR; Lee, TL; Oyerinde, O | 1 |
| Balazic, E; Jaller, JA; Khanna, U; Kobets, K; Konisky, H | 1 |
| Lin, C; Zhu, X | 1 |
3 review(s) available for tranexamic acid and hydroquinone
| Article | Year |
|---|---|
What's New in Pigmentary Disorders.
Topics: alpha-MSH; Antifibrinolytic Agents; Bimatoprost; Dermatologic Agents; Humans; Hydroquinones; Inflammation; Janus Kinase Inhibitors; Keratinocytes; Lasers, Solid-State; Low-Level Light Therapy; Melanocytes; Melanosis; Pigmentation Disorders; Skin Lightening Preparations; Sunscreening Agents; Tranexamic Acid; Vitiligo | 2019 |
Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.
Topics: Cysteamine; Humans; Melanosis; Tranexamic Acid; Treatment Outcome; Zinc Sulfate | 2023 |
Tranexamic acid in melasma: A focused review on drug administration routes.
Topics: Administration, Topical; Adult; Female; Humans; Hydroquinones; Melanosis; Tranexamic Acid; Treatment Outcome; Young Adult | 2023 |
7 trial(s) available for tranexamic acid and hydroquinone
| Article | Year |
|---|---|
Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Topics: Adult; Dermatologic Agents; Double-Blind Method; Female; Humans; Hydroquinones; Liposomes; Melanosis; Middle Aged; Pilot Projects; Skin Cream; Sunscreening Agents; Tranexamic Acid; Treatment Outcome | 2015 |
Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a shor
Topics: Administration, Oral; Administration, Topical; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Single-Blind Method; Time Factors; Tranexamic Acid; Treatment Outcome | 2017 |
Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
Topics: Administration, Topical; Adult; Erythema; Face; Female; Humans; Hydroquinones; Melanins; Melanosis; Microinjections; Middle Aged; Patient Satisfaction; Tranexamic Acid; Treatment Outcome | 2018 |
Clinical observation on tranexamic acid combined with reduced glutathione for the treatment of chloasma.
Topics: Administration, Cutaneous; Adult; Drug Therapy, Combination; Female; Glutathione; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Tranexamic Acid; Treatment Outcome | 2018 |
Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals.
Topics: Adult; Arbutin; Humans; Hydroquinones; Middle Aged; Niacinamide; Saccharomycetales; Skin Lightening Preparations; Skin Pigmentation; Tranexamic Acid | 2019 |
Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroquinones; Melanosis; Middle Aged; Severity of Illness Index; Skin Lightening Preparations; Sunscreening Agents; Tranexamic Acid; Treatment Outcome | 2020 |
Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Prospective Studies; Severity of Illness Index; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Young Adult | 2020 |
6 other study(ies) available for tranexamic acid and hydroquinone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Co-drug strategy for promoting skin targeting and minimizing the transdermal diffusion of hydroquinone and tranexamic acid.
Topics: Administration, Cutaneous; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Female; Hair Follicle; Humans; Hydroquinones; Keratinocytes; Mice, Nude; Spectroscopy, Fourier Transform Infrared; Tranexamic Acid | 2013 |
A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Combined Modality Therapy; Erythema; Facial Dermatoses; Female; Humans; Hydroquinones; Lasers, Solid-State; Low-Level Light Therapy; Melanins; Melanosis; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Skin; Tranexamic Acid | 2017 |
Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Topics: Administration, Cutaneous; Administration, Oral; Chemexfoliation; Clinical Trials as Topic; Combined Modality Therapy; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Low-Level Light Therapy; Melanosis; Retinoids; Skin Lightening Preparations; Tranexamic Acid; Treatment Outcome | 2020 |
A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone.
Topics: Administration, Oral; Adolescent; Adult; Cross-Sectional Studies; Drug Combinations; Female; Hispanic or Latino; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Retrospective Studies; Tranexamic Acid; Treatment Outcome; Young Adult | 2020 |
Efficacy of photorejuvenation combined with tranexamic acid and hydroquinone cream in the treatment of complex facial pigmentation.
Topics: Humans; Hydroquinones; Melanosis; Pigmentation; Retrospective Studies; Tranexamic Acid; Water | 2023 |